Avanos Medical (AVNS) EBIT Growth (3y) (2016 - 2026)
Avanos Medical (AVNS) EBIT Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 13.06% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 51.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.23% |
| Dec 31, 2025 | -46.80% |
| Sep 30, 2025 | -80.16% |
| Jun 30, 2025 | -110.87% |
| Mar 31, 2025 | 6.20% |
| Dec 31, 2024 | -165.35% |
| Sep 30, 2024 | 52.25% |
| Jun 30, 2024 | 42.00% |
| Mar 31, 2024 | 32.43% |
| Dec 31, 2023 | 30.79% |
| Sep 30, 2023 | 141.01% |
| Jun 30, 2023 | -5.27% |
| Mar 31, 2023 | -130.00% |
| Dec 31, 2022 | 92.99% |
| Sep 30, 2022 | 39.37% |
| Jun 30, 2022 | 44.71% |
| Mar 31, 2022 | 32.94% |
| Dec 31, 2021 | -39.23% |
| Sep 30, 2021 | -21.39% |
| Jun 30, 2021 | -41.44% |